Article
Driver Mutation Analysis and PD-L1 Expression in Synchronous Double Primary Lung Cancer.
Applied immunohistochemistry & molecular morphology : AIMM - 1 Apr 2018
Jia Xiaoli, Zhang Liping, Wu Wei, Zhang Wei, Wu Chunyan
Abstract excerpt
Synchronous double primary lung cancer (SDPLC) is detected more frequently than in the past. However, the genetic features, diagnosis, and outcome are not well known. For diagnostic and management applications, we collected 110 lesions from 55 patients who underwent surgical resection to analyze the 5 known driver mutations (EGFR, KRAS, BRAF, EML4-ALK, and ROS1) and programmed cell death ligand 1 (PD-L1)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
